{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:46:03Z","timestamp":1777092363046,"version":"3.51.4"},"reference-count":117,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hypertensive nephropathy (HN) is a leading cause of chronic kidney disease and end-stage renal disease worldwide and results from the long-term effects of hypertension on renal structure and function. The pathogenesis of HN is complex and involves haemodynamic disturbances, renal vascular injury, oxidative stress, chronic inflammation, and progressive interstitial fibrosis. In recent years, increasing attention has focused on the role of non-coding RNAs (ncRNAs)\u2014including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs)\u2014as key regulators of gene expression involved in these processes. This review summarises the current understanding of the molecular mechanisms underlying HN, with particular emphasis on the roles of oxidative stress, activation of the renin\u2013angiotensin\u2013aldosterone system, transforming growth factor beta signalling, and inflammatory and fibrogenic pathways. The contribution of dysregulated ncRNAs to endothelial dysfunction, inflammatory responses, apoptosis, angiogenesis, and renal remodelling and fibrosis is also discussed. Particular attention is given to miRNAs and lncRNAs as mediators of disease progression and potential biomarkers, as well as to the emerging role of circRNAs in hypertensive kidney injury, including their involvement in the regulation of redox balance and intercellular communication. Collectively, available evidence indicates that ncRNAs represent a critical link between haemodynamic stimuli and persistent molecular alterations in renal tissue, highlighting their potential as diagnostic markers and therapeutic targets in HN.<\/jats:p>","DOI":"10.3390\/cells15080701","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:56:56Z","timestamp":1776268616000},"page":"701","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Non-Coding RNA in the Pathogenesis of Hypertensive Nephropathy"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6821-0086","authenticated-orcid":false,"given":"Paulina","family":"Plewa","sequence":"first","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Figiel","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1594-5646","authenticated-orcid":false,"given":"Maciej","family":"\u0106mil","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6080-6104","authenticated-orcid":false,"given":"Patryk","family":"Sk\u00f3rka","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kacper","family":"Kupis","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-1208","authenticated-orcid":false,"given":"Andrzej","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Physiology, Pomeranian Medical University, 70-111 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Arzaghi, H., Ma, Z., Roye, Y., and Musah, S. (2024). Epigenetics of Hypertensive Nephropathy. Biomedicines, 12.","DOI":"10.3390\/biomedicines12112622"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"He, Y., Tang, W., Chen, J., Tang, J., Zheng, Y., Wang, X., Xing, B., Li, X., and Xu, Y. (2025). Global burden of chronic kidney disease due to hypertension (1990\u20132021): A systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-04386-8"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41440-024-01916-z","article-title":"Heterogeneous afferent arteriolopathy: A key concept for understanding blood pressure-dependent renal damage","volume":"47","author":"Kohagura","year":"2024","journal-title":"Hypertens. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/HJH.0000000000001170","article-title":"Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms","volume":"35","author":"Seccia","year":"2017","journal-title":"J. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Costantino, V.V., Gil Lorenzo, A.F., Bocanegra, V., and Vall\u00e9s, P.G. (2021). Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan Through Hsp70. Cells, 10.","DOI":"10.3390\/cells10113146"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/s41440-025-02395-6","article-title":"Vascular injury as a driver of heterogeneous hypertensive nephrosclerosis: Insights from preeclampsia","volume":"48","author":"Ito","year":"2025","journal-title":"Hypertens. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"H135","DOI":"10.1152\/ajpheart.00908.2024","article-title":"Endothelial dysfunction in chronic kidney disease: A clinical perspective","volume":"329","author":"Cho","year":"2025","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Kida, Y. (2020). Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218255"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13578-021-00606-4","article-title":"The renal microcirculation in chronic kidney disease: Novel diagnostic methods and therapeutic perspectives","volume":"11","author":"Li","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4103\/ijn.IJN_187_20","article-title":"Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study","volume":"31","author":"Srinivas","year":"2021","journal-title":"Indian J. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/HYPERTENSIONAHA.125.25069","article-title":"Renal Histology Findings in Malignant Hypertension, a Systematic Review","volume":"83","author":"Maisons","year":"2026","journal-title":"Hypertension"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Patera, F., Gatticchi, L., Cellini, B., Chiasserini, D., and Reboldi, G. (2024). Kidney Fibrosis and Oxidative Stress: From Molecular Pathways to New Pharmacological Opportunities. Biomolecules, 14.","DOI":"10.3390\/biom14010137"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative Stress and Hypertension","volume":"128","author":"Griendling","year":"2021","journal-title":"Circ. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/ars.2013.5259","article-title":"Oxidative stress in hypertension: Role of the kidney","volume":"20","author":"Araujo","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Arendshorst, W.J., Vendrov, A.E., Kumar, N., Ganesh, S.K., and Madamanchi, N.R. (2024). Oxidative Stress in Kidney Injury and Hypertension. Antioxidants, 13.","DOI":"10.3390\/antiox13121454"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.23876\/j.krcp.22.198","article-title":"Upregulation of NADH\/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis","volume":"42","author":"Ha","year":"2023","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.90628.2008","article-title":"Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR","volume":"296","author":"Elks","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1002\/j.2040-4603.2024.tb00287.x","article-title":"Renal Epithelial Mitochondria: Implications for Hypertensive Kidney Disease","volume":"14","author":"Stadler","year":"2023","journal-title":"Compr. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and molecular mechanisms of kidney fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajpath.2012.09.009","article-title":"Transforming growth factor \u03b2-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis","volume":"182","author":"Wu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ren, N., Wang, W.F., Zou, L., Zhao, Y.L., Miao, H., and Zhao, Y.Y. (2023). The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1335094"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"C999","DOI":"10.1152\/ajpcell.00201.2023","article-title":"Hypoxia and renal fibrosis","volume":"325","author":"Naas","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Reiss, A.B., Jacob, B., Zubair, A., Srivastava, A., Johnson, M., and De Leon, J. (2024). Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets. J. Clin. Med., 13.","DOI":"10.3390\/jcm13071881"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2008.11.003","article-title":"NADPH oxidases and angiotensin II receptor signaling","volume":"302","author":"Garrido","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"44911","DOI":"10.1038\/srep44911","article-title":"Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Piko, N., Bevc, S., Hojs, R., and Ekart, R. (2024). Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040418"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Meng, X.M., Tang, P.M., Li, J., and Lan, H.Y. (2015). TGF-\u03b2\/Smad signaling in renal fibrosis. Front. Physiol., 6.","DOI":"10.3389\/fphys.2015.00082"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lv, W., Booz, G.W., Fan, F., Wang, Y., and Roman, R.J. (2018). Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. Front. Physiol., 9.","DOI":"10.3389\/fphys.2018.00105"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"F555","DOI":"10.1152\/ajprenal.00594.2015","article-title":"Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats","volume":"311","author":"Hashmat","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1046\/j.1523-1755.2000.00424.x","article-title":"Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury","volume":"58","author":"Hilgers","year":"2000","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/15353702221091986","article-title":"The potential role of complement alternative pathway activation in hypertensive renal damage","volume":"247","author":"Wang","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e70080","DOI":"10.1111\/1751-7915.70080","article-title":"Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology","volume":"18","author":"Jin","year":"2025","journal-title":"Microb. Biotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1089\/ars.2006.8.1597","article-title":"NADPH oxidases in the kidney","volume":"8","author":"Gill","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/CS20140361","article-title":"Nox and renal disease","volume":"128","author":"Holterman","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MNH.0b013e32832923c3","article-title":"Molecular mechanisms of hypertension: Role of Nox family NADPH oxidases","volume":"18","author":"Sedeek","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2018.06.042","article-title":"Nox4 in renal diseases: An update","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2008.478","article-title":"NADPH oxidase in the kidney: A Janus in determining cell fate","volume":"75","author":"Jiang","year":"2009","journal-title":"Kidney Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/HYPERTENSIONAHA.115.06163","article-title":"Downregulation of Nuclear Factor Erythroid 2-Related Factor and Associated Antioxidant Genes Contributes to Redox-Sensitive Vascular Dysfunction in Hypertension","volume":"66","author":"Lopes","year":"2015","journal-title":"Hypertension"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrneph.2016.54","article-title":"Developmental signalling pathways in renal fibrosis: The roles of Notch, Wnt and Hedgehog","volume":"12","author":"Edeling","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1172\/JCI43025","article-title":"Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans","volume":"120","author":"Bielesz","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MNH.0b013e3283414c88","article-title":"The story of Notch and chronic kidney disease","volume":"20","author":"Sharma","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1111\/jcmm.15295","article-title":"Circular RNA in renal diseases","volume":"24","author":"Jin","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Bravo-V\u00e1zquez, L.A., Paul, S., Col\u00edn-Jurado, M.G., M\u00e1rquez-Gallardo, L.D., Casta\u00f1\u00f3n-Cort\u00e9s, L.G., Banerjee, A., Pathak, S., and Duttaroy, A.K. (2024). Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases. Genes, 15.","DOI":"10.3390\/genes15010123"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A Brief Review on the Mechanisms of miRNA Regulation","volume":"7","author":"Cai","year":"2009","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/biof.1980","article-title":"The role of LncRNA-regulated autophagy in AKI","volume":"49","author":"Wang","year":"2023","journal-title":"BioFactors"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Srivastava, S.P., Goodwin, J.E., Tripathi, P., Kanasaki, K., and Koya, D. (2021). Interactions among Long Non-Coding RNAs and microRNAs Influence Disease Phenotype in Diabetes and Diabetic Kidney Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116027"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1111\/jcmm.13238","article-title":"State of the art technologies to explore long non-coding RNAs in cancer","volume":"21","author":"Salehi","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1080\/15548627.2025.2551683","article-title":"Non-coding RNAs regulate autophagy in kidney disease: Friend or foe?","volume":"21","author":"Li","year":"2025","journal-title":"Autophagy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41590-018-0297-6","article-title":"IL-13 secreted by ILC2s promotes the self-renewal of intestinal stem cells through circular RNA circPan3","volume":"20","author":"Zhu","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41418-018-0220-6","article-title":"Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes","volume":"26","author":"Chen","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","article-title":"Essential Role of MicroRNA-155 in Regulating Endothelium-Dependent Vasorelaxation by Targeting Endothelial Nitric Oxide Synthase","volume":"60","author":"Sun","year":"2012","journal-title":"Hypertension"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000546674","article-title":"Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice","volume":"50","author":"Li","year":"2025","journal-title":"Kidney Blood Press. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.2018020117","article-title":"MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension","volume":"29","author":"Liu","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-Cell\u2013Derived miRNA-214 Mediates Perivascular Fibrosis in Hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"117615","DOI":"10.1016\/j.jep.2023.117615","article-title":"Danhong formula alleviates endothelial dysfunction and reduces blood pressure in hypertension by regulating MicroRNA 24-Phosphatidylinositol 3-Kinase-Serine\/Threonine Kinase-Endothelial Nitric Oxide Synthase axis","volume":"323","author":"Yang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"354517","DOI":"10.1155\/2015\/354517","article-title":"Human miR-221\/222 in Physiological and Atherosclerotic Vascular Remodeling","volume":"2015","author":"Chistiakov","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/10641963.2020.1790585","article-title":"The correlation of circulating miR-29b and inflammatory markers with albuminuria in hypertensive patients","volume":"42","author":"Huang","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Yang, Q., Wang, P., Cai, Y., Cui, Y., Cui, J., Du, X., Chen, Y., and Zhang, T. (2022). Circulating MicroRNA-505 May Serve as a Prognostic Biomarker for Hypertension-Associated Endothelial Dysfunction and Inflammation. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.834121"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1080\/0886022X.2021.1915800","article-title":"MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone","volume":"43","author":"Kara","year":"2021","journal-title":"Ren. Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41467-019-10116-0","article-title":"Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK\/NF-\u03baB\/p65 regulatory axis","volume":"10","author":"Lu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1681\/ASN.2010111168","article-title":"Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis","volume":"22","author":"Zhong","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Peng, Z., Guo, H.Y., Li, Y.Q., Li, J.C., Yang, X.H., Liu, J., Hu, Q.-D., Wang, H.-L., and Wang, L. (2022). The Smad3-dependent microRNA let-7i-5p promoted renal fibrosis in mice with unilateral ureteral obstruction. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.937878"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/CM9.0000000000001922","article-title":"MicroRNA-29b suppresses TGF-\u03b2-induced epithelial-mesenchymal transition in renal interstitium of spontaneously hypertensive rats","volume":"135","author":"Wu","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"14780","DOI":"10.3389\/bjbs.2025.14780","article-title":"Identification of an Exosomal miRNA Signature in Newly Diagnosed Essential Hypertensive Adults","volume":"82","author":"Tan","year":"2025","journal-title":"Br. J. Biomed. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.120.16598","article-title":"Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated with Albuminuria in Hypertension","volume":"77","author":"Ortega","year":"2021","journal-title":"Hypertension"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Liu, C., Ma, K., Zhang, Y., He, X., Song, L., Chi, M., Han, Z., Li, G., Zhang, Q., and Liu, C. (2022). Kidney diseases and long non-coding RNAs in the limelight. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.932693"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Giannuzzi, F., Maiullari, S., Gesualdo, L., and Sallustio, F. (2023). The Mission of Long Non-Coding RNAs in Human Adult Renal Stem\/Progenitor Cells and Renal Diseases. Cells, 12.","DOI":"10.3390\/cells12081115"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lin, J., Jiang, Z., Liu, C., Zhou, D., Song, J., Liao, Y., and Chen, J. (2020). Emerging Roles of Long Non-Coding RNAs in Renal Fibrosis. Life, 10.","DOI":"10.3390\/life10080131"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/HYPERTENSIONAHA.114.04498","article-title":"Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease","volume":"65","author":"Gopalakrishnan","year":"2015","journal-title":"Hypertension"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wang, Z., Liu, Z., Yang, Y., and Kang, L. (2020). Identification of biomarkers and pathways in hypertensive nephropathy based on the ceRNA regulatory network. BMC Nephrol., 21.","DOI":"10.1186\/s12882-020-02142-8"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.7150\/thno.26024","article-title":"Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease","volume":"8","author":"Yu","year":"2018","journal-title":"Theranostics"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: From mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/HYPERTENSIONAHA.120.16395","article-title":"Long Noncoding RNA Tug1 Promotes Angiotensin II\u2013Induced Renal Fibrosis by Binding to Mineralocorticoid Receptor and Negatively Regulating MicroR-29b-3p","volume":"78","author":"Zhang","year":"2021","journal-title":"Hypertension"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e40891","DOI":"10.1016\/j.heliyon.2024.e40891","article-title":"LncRNA TUG1 mitigates chronic kidney disease through miR-542-3p\/HIF-1\u03b1\/VEGF axis","volume":"11","author":"Qian","year":"2025","journal-title":"Heliyon"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13578-024-01217-5","article-title":"The role of long noncoding RNAs in ocular angiogenesis and vascular oculopathy","volume":"14","author":"Gandhi","year":"2024","journal-title":"Cell Biosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11626-024-00990-4","article-title":"Compatibility of Calycosin-Tanshinone IIA improves Ang II-induced renal artery endothelial cell dysfunction through lncRNA-mRNA co-expression network","volume":"61","author":"Jiang","year":"2025","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Pant, T., Uche, N., Juric, M., and Bosnjak, Z.J. (2023). Clinical Relevance of lncRNA and Mitochondrial Targeted Antioxidants as Therapeutic Options in Regulating Oxidative Stress and Mitochondrial Function in Vascular Complications of Diabetes. Antioxidants, 12.","DOI":"10.3390\/antiox12040898"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hu, M., Ma, Q., Liu, B., Wang, Q., Zhang, T., Huang, T., and Lv, Z. (2022). Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.845371"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"101509","DOI":"10.1016\/j.gendis.2024.101509","article-title":"The role of lncRNAs in AKI and CKD: Molecular mechanisms, biomarkers, and potential therapeutic targets","volume":"12","author":"Zheng","year":"2025","journal-title":"Genes Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Xia, W., He, Y., Gan, Y., Zhang, B., Dai, G., Ru, F., Jiang, Z., Chen, Z., and Chen, X. (2021). Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis. Front. Genet., 12.","DOI":"10.3389\/fgene.2021.682904"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s12013-025-01698-2","article-title":"Role of LncRNA in Pathogenesis, Diagnosis and Treatment of Chronic Kidney Disease","volume":"83","author":"He","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"eaat2039","DOI":"10.1126\/scitranslmed.aat2039","article-title":"Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-\u03b2\/Smad3 pathway","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.1016\/j.apsb.2025.09.012","article-title":"Emerging epigenetic modifications in renal fibrosis: From mechanisms to treatments","volume":"15","author":"Suo","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"111373","DOI":"10.1016\/j.cellsig.2024.111373","article-title":"LncRNA H19 accelerates renal fibrosis by negatively regulating the let-7b-5p\/TGF-\u03b2R1\/COL1A1 axis","volume":"123","author":"Li","year":"2024","journal-title":"Cell. Signal."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"sfaf307","DOI":"10.1093\/ckj\/sfaf307","article-title":"Epigenetic mechanisms of salt-sensitive hypertension","volume":"18","author":"Citterio","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/jcmm.14863","article-title":"CircNr1h4 regulates the pathological process of renal injury in salt-sensitive hypertensive mice by targeting miR-155-5p","volume":"24","author":"Lu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"sfaf189","DOI":"10.1093\/ckj\/sfaf189","article-title":"Urinary microvesicles: A window into the kidney","volume":"18","author":"Schnobrich","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Agborbesong, E., Bissler, J., and Li, X. (2023). Liquid Biopsy at the Frontier of Kidney Diseases: Application of Exosomes in Diagnostics and Therapeutics. Genes, 14.","DOI":"10.3390\/genes14071367"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1899282","DOI":"10.1155\/2022\/1899282","article-title":"Exosomal hsa_circ_0008925 from Urine Is Related to Chronic Renal Fibrosis","volume":"2022","author":"Cao","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1080\/07853890.2022.2098374","article-title":"Urinary exosomes derived circRNAs as biomarkers for chronic renal fibrosis","volume":"54","author":"Cao","year":"2022","journal-title":"Ann. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"102807","DOI":"10.1016\/j.omtn.2025.102807","article-title":"Circular RNA encoding relaxin-2 as a potential therapy for liver fibrosis","volume":"37","author":"Zhong","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"18076","DOI":"10.1038\/s41598-023-45188-y","article-title":"Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p\/ITGB1 axis","volume":"13","author":"Xia","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/jpet.122.001280","article-title":"CircRNA_33702 Promotes Renal Fibrosis by Targeting the miR-29b-3p\/WNT1-Inducible Signaling Pathway Protein 1 Pathway","volume":"384","author":"Ai","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-024-05364-8","article-title":"An overview of CCN4 (WISP1) role in human diseases","volume":"22","author":"Singh","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ckj\/sfaa162","article-title":"Hypertensive nephropathy: A major roadblock hindering the advance of precision nephrology","volume":"13","author":"Carriazo","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Todorovi\u0107, P., Pavlovi\u0107, N., Maglica, M., Bajt, P., Kelam, N., Ragu\u017e, F., and Vukojevi\u0107, K. (2025). Non-Coding RNAs as Emerging Regulators in Kidney Pathophysiology: From Molecular Mechanisms to Therapeutic Potential. Genes, 16.","DOI":"10.3390\/genes16111328"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"19418","DOI":"10.1038\/s41598-025-04679-w","article-title":"Identify the co-expressed genes of hypertensive nephropathy and diabetic nephropathy","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3390\/ncrna1030192","article-title":"The Role of MicroRNAs in Kidney Disease","volume":"1","author":"Mukhadi","year":"2015","journal-title":"Non-Coding RNA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/13813455.2021.2023580","article-title":"Long non-coding RNAs as emerging regulators of miRNAs and epigenetics in diabetes-related chronic kidney disease","volume":"130","author":"Shelke","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"31101","DOI":"10.1038\/s41598-025-16013-5","article-title":"Impact of Micro-RNAs as biomarkers for end-stage renal disease related to hypertension and diabetes","volume":"15","author":"Ata","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Li, J., Ma, L., Yu, H., Yao, Y., Xu, Z., Lin, W., Wang, L., Wang, X., and Yang, H. (2021). MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front. Med., 8.","DOI":"10.3389\/fmed.2021.782561"},{"key":"ref_107","first-page":"1728","article-title":"Circular RNA hsa_circ_0014243 may serve as a diagnostic biomarker for essential hypertension","volume":"17","author":"Zheng","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"175220","DOI":"10.1016\/j.ejphar.2022.175220","article-title":"The key roles of non-coding RNAs in the pathophysiology of hypertension","volume":"931","author":"Hussen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ncrna.2025.05.001","article-title":"CircRNA-based AntimiR therapy: A novel approach to hypertension treatment","volume":"13","author":"Tarhriz","year":"2025","journal-title":"Non-Coding RNA Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Zou, Z., Zhou, N., and Zhang, C. (2025). miRNA in the Progression of Diabetic Kidney Disease: New Insight. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27010420"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Loganathan, T.S., Sulaiman, S.A., Abdul Murad, N.A., Shah, S.A., Abdul Gafor, A.H., Jamal, R., and Abdullah, N. (2020). Interactions Among Non-Coding RNAs in Diabetic Nephropathy. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00191"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Singh, D.D., Kim, Y., Choi, S.A., Han, I., and Yadav, D.K. (2023). Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases. Cells, 12.","DOI":"10.3390\/cells12121629"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2015.12.002","article-title":"Circulating microRNAs and hypertension\u2014From new insights into blood pressure regulation to biomarkers of cardiovascular risk","volume":"27","author":"Romaine","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.118.11126","article-title":"Noncoding RNAs in the Regulatory Network of Hypertension","volume":"72","author":"Wu","year":"2018","journal-title":"Hypertension"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Leimena, C., and Qiu, H. (2018). Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19040927"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics\u2014Challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"8771","DOI":"10.7150\/thno.62642","article-title":"Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/8\/701\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:19:40Z","timestamp":1777090780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/8\/701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":117,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cells15080701"],"URL":"https:\/\/doi.org\/10.3390\/cells15080701","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}